Strensiq

An Orbimed-backed biotech launches with $85M and plans for a new kind of DNA medicine
BioPharma Dive
Tue, 10/24/23 - 09:59 am
Rampart Biosciences
OrbiMed
Alexion Pharmaceuticals
Strensiq
hypophosphatasia
14 Drugs Earn Billions for These Massachusetts Biotechs
BioSpace
Wed, 03/6/19 - 09:59 am
Massachusetts
Boston
Biogen
Tecfidera
Benepali
Shire
Takeda
Vyvanse
Vertex Pharmaceuticals
Orkambi
Kalydeco
Alexion
Soliris
Strensiq
Sanofi Genzyme
Lantus
Ironwood Pharmaceuticals
Linzess
Alexion Gets U.K. Approval for High-Cost Drug
Investopedia
Sat, 09/24/16 - 01:29 pm
Alexion
UK
Strensiq
hypophosphatasia
FDA Approves Alexion’s Metabolic Disorder Drug
WSJ Online
Fri, 10/23/15 - 05:06 pm
FDA
Alexion
Strensiq
HPP
Alexion gets EU approval for drug acquired in Synageva deal
Yahoo/Reuters
Tue, 09/1/15 - 06:41 pm
Alexion
Europe
Synageva
Kanuma
Strensiq